Companies & Industry »Company News»Company News Details
Company News Details

BSE   17 Aug 17 | 04:01 PM

481.00 -2.6 (-0.54%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   17 Aug 17 | 03:54 PM

481.60 -1.65 (-0.34%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 465.40 (3.35%)
1 Month : Rs 537.50 (-10.51%)
1 Year : Rs 373.20 (28.89%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

Widgets Magazine

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Widgets Magazine

Sensex

Company Price Gain (%)
Infosys1,021.154.54
Coal India247.054.22
NTPC176.853.97
Bharti Airtel415.952.29
H D F C1,758.150.95

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine